Maximal Tolerated Dose I­-131 Therapy for Advanced Thyroid Cancer and Determination of Iodine Refractory Disease

In patients with thyroid cancer, the thyroid can lose the capacity to concentrate iodine and become refractory to radioiodine therapy. In this video, Daniel Pryma, MD, considers the maximal tolerated dose of radioiodine in patients with advanced thyroid cancer, and describes the distinguishing features of true radioiodine-­refractory disease.

 

 

Related Links


Published

September 23, 2015

Created by

Penn Physician VideoLink